Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Has at least a 1-year history of migraine with or without aura
Age of the patient at the time of migraine onset \< 50 years
History of 4 to 14 migraine days (migraine/probable migraine headache days) per month on average in the 3 months prior to Visit 1 in the Investigator's judgment
Demonstrated compliance with e-diary
You may not be if
Has a history of migraine accompanied by diplopia or decreased level of consciousness and retinal migraine
Has a current diagnosis of chronic migraine, new persistent daily headache, trigeminal autonomic cephalgia (eg, cluster headache), or painful cranial neuropathy
Difficulty distinguishing migraine headache from other headaches
Has a history of malignancy in the prior 5 years, except for adequately treated basal cell or squamous cell skin cancer, or in situ cervical cancer
Has a history of gastric or small intestinal surgery, or has a disease that causes malabsorption
Has a history of hepatitis within previous 6 months
Usage of opioids or barbiturates \> 2 days/month, triptans or ergots ≥ 10 days/month, or simple analgesics (eg, aspirin, non-steroidal anti-inflammatory drugs \[NSAIDs\], acetaminophen) ≥ 15 days/month in the 3 months prior to Visit 1
Pregnant or nursing females
Clareo Health | Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
